Study of QLS5308 in Patients With Advanced Solid Tumors

Clinical trial NCT07462442 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07462442
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Solid Tumors

Start date: 2026-03-28
Primary completion: 2027-06-01
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.